Bronnen:
- Blink B van den, Dillingh MR, Ginns LC, et al. Recombinant human pentraxin-2 therapy in patients with idiopathic pulmonary fibrosis: safety, pharmacokinetics and exploratory efficacy. Eur Respir J. 2016;47:889-97.,A trial to evaluate the efficacy of PRM-151 in subjects with idiopathic pulmonary fibrosis (IPF). ClinicalTrials.gov, NCT02550873. Via: https://clinicaltrials.gov/ct2/show/NCT02550873.